Search

Abstract Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

M
Magnetic Resonance Direct Thrombus Imaging
Moody A. R.
 
Magnetofection – a highly efficient tool for endothelial gene transfer and antisense oligonucleotide delivery in vitro and in vivo
Krötz F., Sohn H. Y., De Wit C., Zahler S., Bürkle M. A., Pohl U., Plank C.
 
Maintenance doses of lepirudin (Refludan), as adjusted by a chromogenic substrate assay (CSA), highly suggest that recommended therapeutical doses should be safely reduced
Piquet P., Doubine S., Parquin F.
 
Maintenance of patient vs. professional competence with patient self testing of the INR – a 6-year experience
Jacobson A., Ruybalid L. R., Gunneman T., Howe B., Peterson M.
 
Malignancy and low-molecular weight-heparin therapy: the MALT trial
Klerk C. P. W., Smorenburg S. M., Otten J. M. M. B., Büller H. R.
 
Malignancy and metastasis is not associated with decreased ADAMTS-13 activity in patients with brain tumors and prostate tumors
Böhm M., Gerlach R., Beecken W. D., Scheuer T., Stier-Brück I., Scharrer I.
 
Malignancy-related thrombotic state is independent of defects in Factor V Leiden, prothrombin 20210 and MTHFR. Results from the initial profiling of cancer patients entering in a secondary prevention of venous thrombosis with enoxaparin (ONCENOX)
Fareed J., Hoppensteadt D., Lietz H., Tobu M., Cort S., Deitcher S. R.
 
Management and outcome of patients with venous thromboembolism: a prospective registry including over 5000 consecutive patients
Monreal M., Suarez C., Gonzalez-Fajardo J.A., Investigators RIETE
 
Management of hospitalized patients with suspected deep vein thrombosis
Verlato F., Chiarion C., Prandoni P., Camporese G., Nardi M. T., Andreozzi G. M.
 
Management of oral anticoagulant therapy in the perioperative period: preliminary results of the application of an operative protocol
Scannapieco G., Rossi M., Pagilara V., Favretto G., Zanardo G., Pauletto P., Di Falco G.
 
Management of oral anticoagulant therapy with Thrombotest® using a whole blood testing device (Thrombotrack®) in comparison to routine laboratory PT
Filippucci E., De Monte P., Boschetti E., Cavalieri G., Gresele P.
 
Management of pulmonary embolism: Can we consider outpatient treatment?
Bond S., Rhodes S., Green E. S., Bell D., Davies C., Pendry K., Wimperis J.
 
Management of refractory postoperative cardiac bleeding with recombinant Factor VIIa (rFVIIa): Cases reported to the hemostasis.com registry
Kessler C., Szurlej D., Von Heymann C.
 
Management of thrombophilia
Bauer K. A.
 
Management of venous thromboembolism during pregnancy
Ginsburg J. S., Bates S. M., Greer I.
 
Management of VWD with VWF/FVll concentrates: Results from current studies and surveys
Federici A.
 
Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of hemophilia
Allen G., Hoffman M., Monroe D. M.
 
Mapping the interaction between uPAR and high molecular weight kininogen
Mahdi F., Kuo A., Shariat-Madar Z., Cines D. B., Schmaier A. H.
 
Marked variation in d-Dimer concentration as determined by four different assays
Brown P. R., Kitchen S., Makris M.
 
Markers of hemostatic activation and protein Z in acute stroke and myocardial infarction: a community based pilot study
Segal H. C., Harrison P., Keeling D., Silver L., Coull A., Rothwell P.
 
Markers of hypercoagulability in Brazilian patients with DVT undergoing oral anti-coagulation therapy
Ferreira M. F. R., Vieira L. M., Dusse L. M. S., Lages G. F. G., Bastos M., Godoi L. C., Fernandes P. S. M., Carvalho M. G.
 
Markers of inflammation, coagulation, endothelial damage and platelet activation in chronic renal disease
Landray M., Townend J., Blann A., Lip G. Y. H.
 
Markers of inflammation, d-dimer and recurrences after a first episode of venous thromboembolism
Cosmi B., Legnani C., Cini M., Guazzaloca G., Coccheri S., Palareti G.
 
Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Gonzalez-Porras J. R., Garcia Escobar I., Sanchez-Guijo F. M., Alberca I., Lopez M. L., Diez Campelo M., Ocio E., Castilla Llorente C., Mateos M. V., San Miguel J. F.
 
Maternal immunization against ‘rare’ platelet antigens as a cause of neonatal alloimmune thrombocytopenic purpura (NATP)
Peterson J. A., Balthazor S. M., Curtis B. R., Aster R. H.
 
Matrix, protease and angiogenesis
Madri J., Pinter E., Enciso J.
 
MCFD2, a second gene defective in combined factor V/factor VIII deficiency, encodes a novel ER protein that interacts with LMAN1 (ERGIC-53) to form a cofactor-specific sorting receptor
Cunningham M., Zhang B., Pipe S. W., Ginsburg D., Kaufman R. J.
 
MCP-1 as early marker for cell activation in septic patients
Hoffmann U., Brückmann M., Dvorsak E., Liebe V., Borggrefe M., Haase K. K., Huhle G.
 
Measurement of synthetic pentasaccharide fondaparinux (arixtra) anti-Xa activity
Depasse F., Gerotziafas G. T., Van Dreden P., Fontaine S., Samama M. M.
 
Measurement of the in-vitro half life and the pathological significance of the transition of anti-thrombin to the latent state
Mushunje A., Zhou A., Evans G., Carrell R. W.
 
Measurement of tissue factor messenger RNA levels in leukocytes from patients with underlying diseases of disseminated intravascular coagulation
Sase T., Wada H., Nishioka J., Abe Y., Nobori T., Shiku H.
 
Mechanism of activation in Eastern tiger snake bite
Ibrahim K., Dauer R., Angerosa T., Parkin D., Thurlow P.
 
Mechanism of decreased plasma von Willebrand Factor-cleaving metalloproteinase activity in patients with collagen vascular disease
Taki M., Yamazaki S., Yasumuro Y., Oh-I C., Fujimura Y., Soejima K.
 
Mechanisms for acquired activated Protein C resistance in cancer patients
Sarig G., Michaeli Y., Lanir N., Brenner B., Haim N.
 
Mechanisms for angiotensin II on tissue factor expression in human peripheral blood monocytes
He M. X., Wen Z. B., He X. F., He S. L.
 
Mechanisms involved in the differential regulation of endothelial cells and lung fibroblasts by the hyaluronan-binding protease
Etscheid M., Beer N., Kreß J., Seitz R., Dodt J.
 
Mechanisms of conformational activation of prothrombin by staphylocoagulase and fibrinogen substrate recognition
Panizzi P. R., Friedrich R., Verhamme I., Anderson P. J., Huber R., Fuentes-Prior P., Bode W., Bock P. E.
 
Mechanisms of Gla domain membrane binding
Furie B.
 
Mechanisms of glycosaminoglycan activation of the serpins in hemostasis
Huntington J.
 
Mechanisms of homeostasis of blood coagulation factors
Kurachi S., Zhang K., Kuwahara M., Kurachi K.
 
Mechanisms of platelet retention in the collagen-coated bead columns
Kaneko M., Takafuta T., Cuyun-Lira O., Suzuki-Inoue K., Satoh K., Arai M., Yatomi Y., Ozaki Y.
 
Mechanotransduction through glycoprotein Iba induces a unique series of morphologic changes in translocating platelets
Maxwell M. J., Dopheide S. M., Turner S., Mistry N., Jackson S. P.
 
Medical and cancer patients - who is at risk of VTE?
Prandoni P.
 
Medical and surgical approach of pseudotumours and blood cysts in hemophiliacs without primary prophylactic replacement therapy
Petrescu C. A. M., Serban M., Tepeneu P.
 
Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report
Repine T., Osswald M.
 
Metalloproteinase 9 and plasmin as secreted markers of complicated atherosclerotic plaques
Leclercq A., Meilhac O., Michel J.-B.
 
Microvesicle and platelet associated tissue factor promote initiation of coagulation
Müller I., Alex M., Klocke A., Morgenstern E., Kotzsch M., Luther T., Zieseniss S., Preissner K., Engelmann B.
 
Mild ADAMTS-13 deficiency in patients with ischemic stroke
Böhm M., Peyvandi F., Krause M., Miesbach W., Von Auer C., Scharrer I.
 
Modulation of clinical phenotype of Glanzmann's Thrombasthenia by the C807T alpha2 gene polymorphism
D'Andrea G., Margaglione M., GLATIT STUDY GROUP‡ 
 
Modulation of factor V levels in plasma by intragenic polymorphisms
Lunghi B., Girelli D., Scanavini D., Grandini A., Martinelli N., Bernardi F.
 
Modulation of systemic and placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications
Sarig G., Aharon A., Lanir N., Goshen H., Drugan A., Blumenfeld Z., Brenner B.
 
Modulation of thrombin signaling by internalization of thrombin and thrombomodulin complex
Huang H. C., Wu C. M., Shi G. Y., Wu H. L.
 
Modulation of uPA activity and neointima formation by gene transfer
Dichek D.
 
Modulation of von Willebrand factor A1 domain binding to glycoprotein Iba by a-thrombin
Ruggeri Z. M., Mendolicchio L., Ware J., Celikel R., Varughese K. I.
 
Molecular analysis of factor XI deficiency in 8 Lebanese families: identification of two novel mutations
Germanos-Haddad M., De Moerloose P., Neerman-Arbez M.
 
Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
Peake I., Goodeve A., Rodeghiero F., Castaman G., Federici A., Battle J., Meyer D., Mazurier C., Goudemand J., Eikenboom J., Schneppenheim R., Budde U., Ingerslev J., Vorlova Z., Habart D., Holmberg L., Lethagen S., Pasi J., Hill F.
 
Molecular basis of inherited anti-thrombin deficiency in Portuguese families: identification of underlying molecular defects and screening for additional thrombotic risk factors
David D., Ribeiro S., Ferrão L., Gago T., Campos M., Crespo F.
 
Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Hewitt J., Duke L. M., Vo H. C., Nguyen V. H., Maxwell A. H., Johnstone S., Chan K-W, Wu J. K., Wadsworth L. D., Macgillivray R. T. A.
 
Molecular dissection of the human TAFI promoter
Boffa M. B., Bastajian N., Garand M., Dillon R., Hamill J. D., Nesheim M. E., Koschinsky M. L.
 
Molecular events involved in factor IXa stimulation by the factor VIII A2 domain
Fribourg C., Van Stempvoort G., Kolkman J. A., Meijer A. B., Mertens K.
 
Molecular genetic analysis in the factor X gene in patients with congenital FX deficiency
Wulff K., Herrmann F. H.
 
Molecular genetic analysis of gene variants in the 5' flanking region of the FVII gene: Identification of a novel mutation in a German family
Wulff K., Schroeder W., Pollmann C., Glenscheck C., Herrmann F. H.
 
Molecular genetics in hemophilia care
Lillicrap D.
 
Molecular genotyping of the Italian cohort of patients with hemophilia B
Belvini D., Salviato R., Radossi P., Tagariello G.
 
Molecular recognition in the protein C anticoagulant pathway
Dahlbäck B., Villoutreix B. O.
 
Molecular risk factors are important causes for the thrombosis in childhood
Papayan K., Baranovskaya S. S., Sirotkina O. V., Volkova M. V., Schwarts E. I.
 
Molecular weight dependent heparin inhibition of endothelial cell stimulation by FGF-2 and VEGF
Khorana A., Sahni A., Altland O. D., Francis C. W.
 
Molecular-weight dependence on the inhibition of procarboxypeptidase U by heparin and a polydeoxyribonucleotide derived antithrombotic agent (Defibrotide)
Florian-Kujawski M., Ma Q., Fareed D., Tobu M., Hoppensteadt D., Iacobelli M., Fareed J.
 
Monitoring factor levels in haemophilia: potency assessment and assay variability
Ingerslev J.
 
Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Paniccia R., Pretelli P., Stefano P. L., Costanzo M., Bandinelli B., Conti A. A., Attanasio M., Pieralli M., Abbate R., Gensini G. F., Prisco D., Paniccia R., Pretelli P., Stefano P. L., Costanzo M., Bandinelli B., Conti A. A., Attanasio M., Pieralli M., Abbate R., Gensini G. F., Prisco D.
 
Monitoring platelet concentrates (PCs) during storage by functional and immunological tests
Gutensohn K., Siemensen M., Brockmann M. A., Kuehnl P.
 
Monitoring the combined effect of integrilin, clopidogrel and aspirin in patients with myocardial infarction by Cone and Plate(let) Analyzer
Shenkman B., Matetzky S., Tamarin I., Savion N., Hod H., Varon D.
 
Monitoring the pharmacokinetic of inhibitor-bypassing agents with a new thrombin generation assay
Turecek P., Varadi K., Keil B., Negrier C., Berntorp E., Astermark J., Bordet J-C., Morfini M., Schwarz H. P., Turecek P. L.
 
Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments
Hsiao G., Sheu J. R.
 
Mortality of Dutch hemophilia patients, a prospective follow-up of 973 patients, 1992–2002
Plug I., Peters M., Mauser-Bunschoten E. P., De Goede-Bolder A., Heijnen L., Smit C., Willemse J., Rosendaal F. R.
 
MTHFR C677T, Prothrombin G20210A and Factor V Leiden gene mutations in 80 patients with thromboembolic disease – the Singapore experience
Lim L.
 
M-thrombin (Tris-coupled thrombin) is a novel potent agonist of platelet activation with minimum effect on clot formation
Sakurai Y., Takeyama M., Shima M., Hosokawa K., Kasuda S., Nishiya K., Koide T., Yoshioka A.
 
Multicenter comparison of assays for von Willebrand factor-cleaving protease (ADAMTS13) activity
Studt J. D., Böhm M., Budde U., Girma J. P., Lämmle B.
 
Multicenter evaluation of a new polymer tube (Vacuette Sandwich) for coagulation testing. Effect on routine coagulation tests and on plasma levels of markers of coagulation activation
Arnoux D., Borg J. Y., Delahousse B., Robert A., Toulon P. A.
 
Multicenter study of the DGTI: factor VIII determination of FVIII products with a chromogenic method®
Kotitschke R., Kirchmaier C.-M., Germer M., DGTI STUDY GROUP‡ 
 
Multi-diagnostic retrospective study of risk factors of thrombosis in children with cancer – is there a space for multivariate predictive modeling?
Blatny J., Sterba J., Penka M., Dusek L., Koptikova J.
 
Multimerin supports platelet adhesion by functioning as an RGD ligand for platelet integrin receptors
Joshi N. B. J., Zheng S., Kelton D., Horsewood I., Sandhu A. S., Hayward C. P. M.
 
Multiplex PCR Nanogen gene chip assay for thrombospondin mutations associated with acute coronary syndromes
Kottke-Marchant K., Gerber C. E.
 
Multivariate investigation of determinants of oral anti-coagulant stability
Engova D., Duggan C., Shearer M., Arain S., Harrington D., Mcelwaine S., Cotter F., Madhani M., Maccallum P.
 
Mural thrombus generation in classic hemophilia under whole blood flow conditions
Mizuno T., Sugimoto M., Matsui H., Hamada M., Miyata S., Matsuda M., Yoshioka A.
 
Murine (m) aIIb out-competes human (h) aIIb for mouse b3 in a transgenic mouse model: Implications for integrin subunit interactions
Thornton M. A., Zhang C., Frampton J., Kowalska M. A., Poncz M.
 
Mutation analysis and HLA genotype in patients with inhibitors and hemophilia A
Escobar M., White G. C.
 
Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Goodeve A., Peake I., Hashemi M., Al-Buhairan A., Castaman G., Barronciani L., Battle J., Ribba A.-S., Eikenboom J., Oyen F., Christianansen K., Habart D., Lethagen S., Pasi J., Guilliatt A., Surdhar S., Enayat S., Lester W.
 
Mutation of cysteines 1157 or 1234 located within the D3 domain of Von Willebrand Factor causes intracellular retention of high molecular weight multimers
Stepanian A., Hommais A., Fressinaud E., Mazurier C., Girma J. P., Meyer D., Ribba A. S.
 
Mutation profiling in congenital FXIIIA deficiency: detection of 6 novel mutations
Ivaskevicius V., Hilgenfeld R., Sicker T., Brackmann H. - H., Eberl W., Kurnik K., Seitz R., Worsley A., Guerin V., Seifried E., Oldenburg J.
 
Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Oldenburg J., Rost S., Fregin A., Kavakli K., Koch D., Compes M., Eberl W., Wolz W., Schurgers L. J., Vermeer C., Seifried E., Mueller C. R.
 
Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers
Corral J., González-Conejero R., Mushunje A., Navarro M., Marco P., Huntington J. A., Vicente V., Carrell R. W.
 
Mutations of ADAMTS13 gene in four Japanese families with Upshaw–Schulman syndrome
Matsumoto M., Kokame K., Soejima K., Nakagaki T., Yagi H., Ishizashi H., Miyata T., Fujimura Y.
 
Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
Zalavras C., Giotopoulou S., Zibis A. H., Dokou E., Dailiana Z., Xanthi E., Malizos K. N., Kolaitis N., Vartholomatos G.
 
Myocardial infarction in young patients: risk factors and thrombophilia study
Marco P., Roldan V., Pineda J., Marin F., Martinez J. G., Sogorb F.